189 related articles for article (PubMed ID: 10920922)
21. Lack of prognostic significance of nm23 expression in human primary breast cancer.
Göhring UJ; Eustermann I; Becker M; Neuhaus W; Rein DT; Schöndorf T
Oncol Rep; 2002; 9(6):1205-8. PubMed ID: 12375020
[TBL] [Abstract][Full Text] [Related]
22. NM23 expression as prognostic factor in colorectal carcinoma.
Forte A; D'Urso A; Gallinaro LS; Lo Storto G; Soda G; Bosco D; Bezzi M; Vietri F; Beltrami V
G Chir; 2002 Mar; 23(3):61-3. PubMed ID: 12109225
[TBL] [Abstract][Full Text] [Related]
23. Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness.
Tang Z; Qin L; Wang X; Zhou G; Liao Y; Weng Y; Jiang X; Lin Z; Liu K; Ye S
Chin Med J (Engl); 1998 Apr; 111(4):313-8. PubMed ID: 10374394
[TBL] [Abstract][Full Text] [Related]
24. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
25. [The expression of nm23-H1 genes with clinical prognosis in endometrial carcinoma].
Guo C; Wei L; Fu Q
Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):423-5. PubMed ID: 11360656
[TBL] [Abstract][Full Text] [Related]
26. Usefulness and limitation of multiple endoscopic biopsy sampling for epidermal growth factor receptor and c-erbB-2 testing in patients with gastric adenocarcinoma.
Kimura M; Tsuda H; Morita D; Shinto E; Tanimoto T; Ichikura T; Mochizuki H; Matsubara O
Jpn J Clin Oncol; 2005 Jun; 35(6):324-31. PubMed ID: 15928192
[TBL] [Abstract][Full Text] [Related]
27. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
[TBL] [Abstract][Full Text] [Related]
28. The role of nm23-H1 in the progression of transitional cell bladder cancer.
Chow NH; Liu HS; Chan SH
Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
[TBL] [Abstract][Full Text] [Related]
29. Expression of the p53 and nm23 genes in cholesteatoma.
Bayazit YA; Bakir K; Kanlikama M; Ozer E; Mumbuc S; Disikirik I; Ucak R
Acta Otolaryngol; 2002 Oct; 122(7):726-9. PubMed ID: 12484649
[TBL] [Abstract][Full Text] [Related]
30. [Expression of nm23 and c-erbB-2 proteins in cells of primary colorectal cancer and its metastases].
Delektorskaia VV; Perevoshchikov AG; Kushlinskiĭ NE
Arkh Patol; 2003; 65(5):11-5. PubMed ID: 14664140
[TBL] [Abstract][Full Text] [Related]
31. Expression of nm23 in the primary tumor and the metastatic regional lymph nodes of patients with gastric cardiac cancer.
Hsu NY; Chow KC; Chen WJ; Lin CC; Chou FF; Chen CL
Clin Cancer Res; 1999 Jul; 5(7):1752-7. PubMed ID: 10430079
[TBL] [Abstract][Full Text] [Related]
32. Expression of p53 and NDP-K/nm23 in gastric carcinomas--association with metastasis and clinicopathologic parameters.
Kim KM; Lee A; Chae HS; Shim SI
J Korean Med Sci; 1995 Dec; 10(6):406-13. PubMed ID: 8924224
[TBL] [Abstract][Full Text] [Related]
33. Prediction of distant metastases after curative surgery for rectal cancer.
Günther K; Dworak O; Remke S; Pflüger R; Merkel S; Hohenberger W; Reymond MA
J Surg Res; 2002 Mar; 103(1):68-78. PubMed ID: 11855920
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of transforming growth factor beta 1 and nm-23 H1 antioncogene in prostate cancer: divergent correlation with clinicopathological parameters.
Stravodimos K; Constantinides C; Manousakas T; Pavlaki C; Pantazopoulos D; Giannopoulos A; Dimopoulos C
Anticancer Res; 2000; 20(5C):3823-8. PubMed ID: 11268461
[TBL] [Abstract][Full Text] [Related]
35. [Immunohistochemical analysis of c-erB-2 and nm23 expression in early gastric carcinoma].
Aoyagi K; Koufuji K; Kodama I; Ohta J; Takamiya H; Mizutani K; Takeda J; Shirouzu K
Nihon Shokakibyo Gakkai Zasshi; 1996 Sep; 93(9):613-9. PubMed ID: 8965386
[TBL] [Abstract][Full Text] [Related]
36. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
[TBL] [Abstract][Full Text] [Related]
37. Immunoreactivity of nm23-H1 protein in renal cell carcinoma.
Kuo JY; Chang KM; Chen KK; Chang LS
Anticancer Res; 1998; 18(1B):531-6. PubMed ID: 9568173
[TBL] [Abstract][Full Text] [Related]
38. [The role of nm23 protein in progression of sporadic adenocarcinoma of the large intestine].
Paluszkiewicz P; Pawłowska-Wakowicz B; Karski J
Wiad Lek; 1997; 50 Suppl 1 Pt 1():82-6. PubMed ID: 9446409
[TBL] [Abstract][Full Text] [Related]
39. Value of c-erbB-2 and p53 oncoprotein co-overexpression in human breast cancer.
Barbati A; Cosmi EV; Sidoni A; Collini P; Porpora MG; Ferri I; Lüthy M; Lauro V; Bucciarelli E
Anticancer Res; 1997; 17(1A):401-5. PubMed ID: 9066684
[TBL] [Abstract][Full Text] [Related]
40. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
